AU5744890A - Association of l-5-hydroxy-tryptophane with benserazide as a pharmaceutical composition to be used in the treatment of problems of balance and ataxia, cerebellar or other, irrespective of origin, and its use for the preparation of said composition - Google Patents

Association of l-5-hydroxy-tryptophane with benserazide as a pharmaceutical composition to be used in the treatment of problems of balance and ataxia, cerebellar or other, irrespective of origin, and its use for the preparation of said composition

Info

Publication number
AU5744890A
AU5744890A AU57448/90A AU5744890A AU5744890A AU 5744890 A AU5744890 A AU 5744890A AU 57448/90 A AU57448/90 A AU 57448/90A AU 5744890 A AU5744890 A AU 5744890A AU 5744890 A AU5744890 A AU 5744890A
Authority
AU
Australia
Prior art keywords
composition
benserazide
tryptophane
cerebellar
ataxia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57448/90A
Inventor
Paul Trouillas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5744890A publication Critical patent/AU5744890A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU57448/90A 1989-05-25 1990-05-23 Association of l-5-hydroxy-tryptophane with benserazide as a pharmaceutical composition to be used in the treatment of problems of balance and ataxia, cerebellar or other, irrespective of origin, and its use for the preparation of said composition Abandoned AU5744890A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8907129 1989-05-25
FR8907129A FR2647345B1 (en) 1989-05-25 1989-05-25 COMBINATION OF L-5-HYDROXY-TRYPTOPHANE AND BENSERAZIDE AS A PHARMACEUTICAL COMPOSITION, ESPECIALLY USEFUL IN THE TREATMENT OF CEREBELOUS AND OTHER DISORDERS OF BALANCE AND ATAXIA, OF ALL ORIGINS, AND ITS USE FOR THE PREPARATION OF LADITE COMPOSITION

Publications (1)

Publication Number Publication Date
AU5744890A true AU5744890A (en) 1990-12-18

Family

ID=9382183

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57448/90A Abandoned AU5744890A (en) 1989-05-25 1990-05-23 Association of l-5-hydroxy-tryptophane with benserazide as a pharmaceutical composition to be used in the treatment of problems of balance and ataxia, cerebellar or other, irrespective of origin, and its use for the preparation of said composition

Country Status (3)

Country Link
AU (1) AU5744890A (en)
FR (1) FR2647345B1 (en)
WO (1) WO1990014085A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004039196B4 (en) * 2004-08-12 2008-07-31 Dr.Kamprad Kg New formulation for L-tryptophan
FR2928546B1 (en) * 2008-03-17 2013-08-02 Oreal USE OF DOPA DECARBOXYLASE INHIBITORS FOR CAPILLARY PIGMENTATION.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932652A (en) * 1972-06-30 1976-01-13 Hoffmann-La Roche Inc. Antidepressant compositions

Also Published As

Publication number Publication date
FR2647345A1 (en) 1990-11-30
FR2647345B1 (en) 1992-08-28
WO1990014085A1 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
CS141387A2 (en) Microbicide
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
AU4470389A (en) Hair treatment compositions to impart durable hair set retention properties
AU5745290A (en) Improvements in or relating to medical ventilators
AU5227890A (en) Composition and use
CA2210872A1 (en) Dried composition
AU5561690A (en) Improvements in or relating to pharmaceutical preparations
DK1167354T3 (en) Racemic hypersensitivity A
CA2015186A1 (en) Nutrient composition
GB2170709B (en) Pharmaceutical compositions with analgesic properties and the preparation and use thereof
DK616186D0 (en) PHARMACEUTICAL PREPARATION WITH DELAYED RELEASE OF IBUPROFEN
AU6732190A (en) Use of guanidinoacetic acid to induce an increase of the creatine contents in muscles
AU6285390A (en) Improvements in or relating to i.c. engines
AU5744890A (en) Association of l-5-hydroxy-tryptophane with benserazide as a pharmaceutical composition to be used in the treatment of problems of balance and ataxia, cerebellar or other, irrespective of origin, and its use for the preparation of said composition
MD970269A (en) Clavulanates
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
AU1789788A (en) Cyclopolyglycuronic acid composition and its use
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
AU3275489A (en) Improvements in or relating to pharmaceutical compounds and compositions
IL93135A0 (en) Pyridylalkylamine derivatives,their preparation and the use thereof as production promoters in livestock and as agents against obesity
AU5565890A (en) An acaricidal composition and use thereof in disinfesting treatments
AU5042890A (en) Composition and treatment with peptide combinations
GB8917849D0 (en) Thiazole derivatives,their preparation and their use as fungicides
GR3015373T3 (en) 2-Halogen-substituted N-indolyl sulfonic-acid amides, process for their preparation and their pharmaceutical use.
AU6638290A (en) Improvements in and relating to duckboards